American International Group, Inc. Share Price Target ‘$85.00’, now 7.8% Upside Potential

DirectorsTalk Interviews

American International Group, Inc. with ticker code (AIG) now have 16 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $92.00 and $75.00 calculating the average target share price we see $85.00. (at the time of writing). Now with the previous closing price of $78.82 this now indicates there is a potential upside of 7.8%. The day 50 moving average is $77.09 while the 200 day moving average is $68.44. The company has a market cap of 51.98B. The stock price is currently at: $78.32 USD

The potential market cap would be $56,053,923,435 based on the market consensus.

The company has a dividend yield of 0.89%. Other points of data to note are a P/E ratio of 11.71, revenue per share of $68.56 and a 0.82% return on assets.

American International Group, Inc. is a global insurance company. The Company provides a range of property and casualty insurance, life insurance, retirement solutions, and other financial services to customers in over 70 countries and jurisdictions. Its diverse offerings include products and services that help businesses and individuals protect their assets, manage risks and provide for retirement security. It operates through three segments: General Insurance, Life and Retirement, and Other Operations. Its General Insurance segment consists of two segments: North America and International. Its Life and Retirement segment consists of four segments: Individual Retirement, Group Retirement, Life Insurance and Institutional Markets. Its North America and International segments consist of two product categories: Commercial Lines, which consists of Liability, Financial Lines, Property and Global Specialty, and Personal Insurance, which consists of Personal Lines, and Accident and Health.

Share on:
Find more news, interviews, share price & company profile here for:

    Nuformix raises £210,000 to advance NXP002 and US Orphan Drug Application

    Nuformix plc (LON:NFX) aims to raise £210,000 through a conditional placing to advance its NXP002 inhalation treatment for IPF and PPF.

    Likewise grants over 3.1m shares under 2025 SAYE scheme

    Likewise Group plc (LON:LIKE) has successfully closed its 2025 Save As You Earn Scheme, granting options to 69 employees on over 3.1 million shares.

    Zotefoams reports record £50.7m revenue in strong start to 2025

    Zotefoams Plc reports strong sales growth of 8% and record revenue for the first four months of 2025, showcasing a successful strategic pivot into key markets.

    Ilika announces £3.5m fundraise via Placing and Retail Offer

    Ilika Plc, a leader in solid-state battery technology, plans to raise approximately £3.0 million through a new share placing and a retail offer for shareholders.

    KEFI Gold and Copper raises £7m to advance Tulu Kapi Gold project

    KEFI Gold and Copper Plc has successfully raised £7 million to advance its Tulu Kapi Gold Project in Ethiopia, following crucial parliamentary developments.

    Arbuthnot Banking Group reports stable loan book and 17% deposit growth

    Arbuthnot Banking Group PLC reveals key trading performance insights for April 2025, highlighting growth in deposits and adjusting its lending strategy amid economic uncertainty.

      Search

      Search